GBT
CELG

Grove Bank & Trust’s Celgene Corp CELG Stock Holding History

Grove Bank & Trust’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,292
Closed -$448K – 520
2017
Q4 		$448K Sell
4,292
-463
-10% -$52.2K 0.2% 114
2017
Q3 		$694K Buy
4,755
+698
+17% +$95.1K 0.34% 76
2017
Q2 		$526K Buy
4,057
+1,392
+52% +$171K 0.34% 75
2017
Q1 		$331K Buy
2,665
+261
+11% +$31.2K 0.27% 71
2016
Q4 		$278K Buy
2,404
+450
+23% +$50.1K 0.21% 84
2016
Q3 		$205K Buy
1,954
+1,250
+178% +$135K 0.17% 98
2016
Q2 		$69K Buy
704
+20
+3% +$2.07K 0.06% 138
2016
Q1 		$68K Hold
684
– – 0.06% 142
2015
Q4 		$82K Buy
+684
New +$79.1K 0.07% 141

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Grove Bank & Trust's CELG Position: Q1 2018 in Review

Grove Bank & Trust sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 4,292 shares — an estimated $448K sold.

Grove Bank & Trust first reported a position in CELG in Q4 2015 and held it in 9 quarters. The position peaked at $694K in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Grove Bank & Trust reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Grove Bank & Trust sold 4,292 Celgene Corp shares in Q1 2018, an estimated $448K.
  • Grove Bank & Trust first reported a position in Celgene Corp in Q4 2015 and held it in 9 quarters.
  • Grove Bank & Trust's Celgene Corp position peaked at $694K in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Grove Bank & Trust's 13F filing for Q1 2018, filed 7 May 2018.